Translating the Investigator’s Static Global Assessment to the Eczema Area and Severity Index in Studies of Crisaborole for Atopic Dermatitis

INTRODUCTION: Atopic dermatitis (AD) severity was measured in two phase 3 US studies of crisaborole ointment, 2%, in patients aged ≥ 2 years using the Investigator’s Static Global Assessment (ISGA), an FDA-recommended scale. Eczema Area and Severity Index (EASI) is a validated scale used globally to...

Descripción completa

Detalles Bibliográficos
Autores principales: Thyssen, Jacob P., Zang, Chuanbo, Neary, Maureen P., Bushmakin, Andrew G., Cappelleri, Joseph C., Cha, Amy, Russo, Christopher, Luger, Thomas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163913/
https://www.ncbi.nlm.nih.gov/pubmed/33728583
http://dx.doi.org/10.1007/s13555-021-00509-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163913/
https://www.ncbi.nlm.nih.gov/pubmed/33728583
http://dx.doi.org/10.1007/s13555-021-00509-9

Ejemplares similares